Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
株式のランク #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
株価
$37.45
時価総額
$166.43B
変化(1日)
-2.55%
変化(1年)
-53.09%
DK
取引 Novo Nordisk A/S (NVO)

カテゴリー

Novo Nordisk A/S(NVO)の株式分割履歴
Novo Nordisk A/S株(シンボル:NVO)は合計で2回の株式分割を実施しました。
最新の株式分割はSep 13, 2023に行われました。
Jan 02, 2014より前に購入されたNVO株は、現在10NVO株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2023-09-13 2:1 x2 x10
2014-01-02 5:1 x5 x5
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
US
0 -
BE
1 x3
AU
0 -
NL